How do you find using the New Zealand Gazette? Please give your feedback by completing this survey.

Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product:

Active Ingredients:


Dosage Form:

New Zealand Sponsor:
Manufacturer:

Glycopyrronium Bromide 0.5mg/mL and
Neostigmine Metilsulfate 2.5mg/mL Injection

Glycopyrronium bromide 0.5mg/mL
Neostigmine metilsulfate 2.5mg/mL
Solution for injection
Max Health Limited
Martindale Pharmaceuticals, Essex, United Kingdom

Note: This renewed consent is valid for two years from 18 July 2015.

Dated this 9th day of July 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).